Predicting outcome in mild cognitive impairment: 4-year follow-up study

Jane A. Lonie, Mario A. Parra=Rodriguez, Kevin M. Tierney, Lucie L. Herrmann, Claire Donaghey, Ronan E. O'Carroll, Klaus P. Ebmeier

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

BackgroundCognitive impairment precedes the diagnosis of Alzheimer's disease. It is unclear which psychometric measures predict dementia, and what cut-off points should be used. Replicable cognitive measures to provide information about differential diagnosis and prognosis would be clinically useful.AimsIn a prospective cohort study we investigated which measures distinguish between individuals with amnestic mild cognitive impairment (aMCI) that converts to dementia and those whose impairment does not, and which combination of measures best predicts the fate of people with aMCI.MethodForty-four participants with aMCI underwent extensive neuropsychological assessment at baseline and annually thereafter for an average of 4 years. Differences in baseline cognitive performance of participants who were converters and non-converters to clinically diagnosed dementia were analysed, Classification accuracy was estimated by sensitivity, specificity, positive and negative predictive values and using logistic regression.ResultsForty-one percent of participants had progressed to dementia by the end of study, with a mean annual conversion rate of 11%. Most (63%) showed persisting or progressive cognitive impairment, irrespective of diagnosis. The Addenbrooke's Cognitive Examination together with the discrimination index of the Hopkins Verbal Learning Test Revised (but none of the demographic indices) differentiated the participants who were converters from the non-converters at baseline with 74% accuracy.ConclusionsTargeted neuropsychological assessment, beyond simple cognitive screening, could be used in clinical practice to provide individuals with aMCI with prognostic information and aid selective early initiation of monitoring and treatment among those who progress towards a clinically diagnosable dementia.
LanguageEnglish
Pages135-140
Number of pages6
JournalBritish Journal of Psychiatry
Volume197
Issue number2
DOIs
Publication statusPublished - Aug 2010

Fingerprint

Dementia
Verbal Learning
Psychometrics
Alzheimer Disease
Differential Diagnosis
Cohort Studies
Logistic Models
Demography
Cognitive Dysfunction
Prospective Studies
Sensitivity and Specificity

Keywords

  • mild cognitive impairment
  • Alzheimer's disease
  • cohort study
  • neuropsychological assessment

Cite this

Lonie, J. A., Parra=Rodriguez, M. A., Tierney, K. M., Herrmann, L. L., Donaghey, C., O'Carroll, R. E., & Ebmeier, K. P. (2010). Predicting outcome in mild cognitive impairment: 4-year follow-up study. British Journal of Psychiatry , 197(2), 135-140. https://doi.org/10.1192/bjp.bp.110.077958
Lonie, Jane A. ; Parra=Rodriguez, Mario A. ; Tierney, Kevin M. ; Herrmann, Lucie L. ; Donaghey, Claire ; O'Carroll, Ronan E. ; Ebmeier, Klaus P. / Predicting outcome in mild cognitive impairment : 4-year follow-up study. In: British Journal of Psychiatry . 2010 ; Vol. 197, No. 2. pp. 135-140.
@article{0edb4726e5c84db49db39d1c50cbbd10,
title = "Predicting outcome in mild cognitive impairment: 4-year follow-up study",
abstract = "BackgroundCognitive impairment precedes the diagnosis of Alzheimer's disease. It is unclear which psychometric measures predict dementia, and what cut-off points should be used. Replicable cognitive measures to provide information about differential diagnosis and prognosis would be clinically useful.AimsIn a prospective cohort study we investigated which measures distinguish between individuals with amnestic mild cognitive impairment (aMCI) that converts to dementia and those whose impairment does not, and which combination of measures best predicts the fate of people with aMCI.MethodForty-four participants with aMCI underwent extensive neuropsychological assessment at baseline and annually thereafter for an average of 4 years. Differences in baseline cognitive performance of participants who were converters and non-converters to clinically diagnosed dementia were analysed, Classification accuracy was estimated by sensitivity, specificity, positive and negative predictive values and using logistic regression.ResultsForty-one percent of participants had progressed to dementia by the end of study, with a mean annual conversion rate of 11{\%}. Most (63{\%}) showed persisting or progressive cognitive impairment, irrespective of diagnosis. The Addenbrooke's Cognitive Examination together with the discrimination index of the Hopkins Verbal Learning Test Revised (but none of the demographic indices) differentiated the participants who were converters from the non-converters at baseline with 74{\%} accuracy.ConclusionsTargeted neuropsychological assessment, beyond simple cognitive screening, could be used in clinical practice to provide individuals with aMCI with prognostic information and aid selective early initiation of monitoring and treatment among those who progress towards a clinically diagnosable dementia.",
keywords = "mild cognitive impairment, Alzheimer's disease, cohort study, neuropsychological assessment",
author = "Lonie, {Jane A.} and Parra=Rodriguez, {Mario A.} and Tierney, {Kevin M.} and Herrmann, {Lucie L.} and Claire Donaghey and O'Carroll, {Ronan E.} and Ebmeier, {Klaus P.}",
year = "2010",
month = "8",
doi = "10.1192/bjp.bp.110.077958",
language = "English",
volume = "197",
pages = "135--140",
journal = "British Journal of Psychiatry",
issn = "0007-1250",
number = "2",

}

Lonie, JA, Parra=Rodriguez, MA, Tierney, KM, Herrmann, LL, Donaghey, C, O'Carroll, RE & Ebmeier, KP 2010, 'Predicting outcome in mild cognitive impairment: 4-year follow-up study' British Journal of Psychiatry , vol. 197, no. 2, pp. 135-140. https://doi.org/10.1192/bjp.bp.110.077958

Predicting outcome in mild cognitive impairment : 4-year follow-up study. / Lonie, Jane A.; Parra=Rodriguez, Mario A.; Tierney, Kevin M.; Herrmann, Lucie L.; Donaghey, Claire; O'Carroll, Ronan E.; Ebmeier, Klaus P.

In: British Journal of Psychiatry , Vol. 197, No. 2, 08.2010, p. 135-140.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Predicting outcome in mild cognitive impairment

T2 - British Journal of Psychiatry

AU - Lonie, Jane A.

AU - Parra=Rodriguez, Mario A.

AU - Tierney, Kevin M.

AU - Herrmann, Lucie L.

AU - Donaghey, Claire

AU - O'Carroll, Ronan E.

AU - Ebmeier, Klaus P.

PY - 2010/8

Y1 - 2010/8

N2 - BackgroundCognitive impairment precedes the diagnosis of Alzheimer's disease. It is unclear which psychometric measures predict dementia, and what cut-off points should be used. Replicable cognitive measures to provide information about differential diagnosis and prognosis would be clinically useful.AimsIn a prospective cohort study we investigated which measures distinguish between individuals with amnestic mild cognitive impairment (aMCI) that converts to dementia and those whose impairment does not, and which combination of measures best predicts the fate of people with aMCI.MethodForty-four participants with aMCI underwent extensive neuropsychological assessment at baseline and annually thereafter for an average of 4 years. Differences in baseline cognitive performance of participants who were converters and non-converters to clinically diagnosed dementia were analysed, Classification accuracy was estimated by sensitivity, specificity, positive and negative predictive values and using logistic regression.ResultsForty-one percent of participants had progressed to dementia by the end of study, with a mean annual conversion rate of 11%. Most (63%) showed persisting or progressive cognitive impairment, irrespective of diagnosis. The Addenbrooke's Cognitive Examination together with the discrimination index of the Hopkins Verbal Learning Test Revised (but none of the demographic indices) differentiated the participants who were converters from the non-converters at baseline with 74% accuracy.ConclusionsTargeted neuropsychological assessment, beyond simple cognitive screening, could be used in clinical practice to provide individuals with aMCI with prognostic information and aid selective early initiation of monitoring and treatment among those who progress towards a clinically diagnosable dementia.

AB - BackgroundCognitive impairment precedes the diagnosis of Alzheimer's disease. It is unclear which psychometric measures predict dementia, and what cut-off points should be used. Replicable cognitive measures to provide information about differential diagnosis and prognosis would be clinically useful.AimsIn a prospective cohort study we investigated which measures distinguish between individuals with amnestic mild cognitive impairment (aMCI) that converts to dementia and those whose impairment does not, and which combination of measures best predicts the fate of people with aMCI.MethodForty-four participants with aMCI underwent extensive neuropsychological assessment at baseline and annually thereafter for an average of 4 years. Differences in baseline cognitive performance of participants who were converters and non-converters to clinically diagnosed dementia were analysed, Classification accuracy was estimated by sensitivity, specificity, positive and negative predictive values and using logistic regression.ResultsForty-one percent of participants had progressed to dementia by the end of study, with a mean annual conversion rate of 11%. Most (63%) showed persisting or progressive cognitive impairment, irrespective of diagnosis. The Addenbrooke's Cognitive Examination together with the discrimination index of the Hopkins Verbal Learning Test Revised (but none of the demographic indices) differentiated the participants who were converters from the non-converters at baseline with 74% accuracy.ConclusionsTargeted neuropsychological assessment, beyond simple cognitive screening, could be used in clinical practice to provide individuals with aMCI with prognostic information and aid selective early initiation of monitoring and treatment among those who progress towards a clinically diagnosable dementia.

KW - mild cognitive impairment

KW - Alzheimer's disease

KW - cohort study

KW - neuropsychological assessment

UR - http://www.scopus.com/inward/record.url?scp=77955370974&partnerID=8YFLogxK

U2 - 10.1192/bjp.bp.110.077958

DO - 10.1192/bjp.bp.110.077958

M3 - Article

VL - 197

SP - 135

EP - 140

JO - British Journal of Psychiatry

JF - British Journal of Psychiatry

SN - 0007-1250

IS - 2

ER -